scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/B978-0-12-571146-3.50009-2 |
P698 | PubMed publication ID | 1704143 |
P50 | author | Ron Rosenfeld | Q91337168 |
P2093 | author name string | Y. Oh | |
C. Conover | |||
G. Lamson | |||
H. Pham | |||
D. D. De Leon | |||
I. Ocrant | |||
L. Giudice | |||
S. M. Donovan | |||
P2860 | cites work | Cancer Research | Q326097 |
Demonstration that a Human Hepatoma Cell Line Produces a Specific Insulin-Like Growth Factor Carrier Protein* | Q63533194 | ||
Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity | Q67017882 | ||
Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels | Q67457885 | ||
Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay | Q67583755 | ||
Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells | Q67653409 | ||
Demonstration of specific plasma protein binding sites for somatomedin | Q67715288 | ||
Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors | Q67967882 | ||
Insulin-like growth factor II precursor gene organization in relation to insulin gene family | Q24301476 | ||
Cloning, characterization, and expression of a human insulin-like growth factor binding protein | Q24337523 | ||
Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1) | Q24563737 | ||
Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids | Q28236435 | ||
Structure of the human chromosomal gene for the 25 kilodalton insulin-like growth factor binding protein | Q28238350 | ||
Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II | Q28254078 | ||
New perspectives in cell adhesion: RGD and integrins | Q28280381 | ||
Organization of the gene encoding the insulin-like growth factor binding protein IBP-1 | Q28281708 | ||
Insulin-like growth factor II receptor as a multifunctional binding protein | Q28285510 | ||
Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma | Q28303401 | ||
Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA | Q28308108 | ||
Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors | Q28308163 | ||
Structure of the receptor for insulin-like growth factor II: the puzzle amplified | Q33365794 | ||
Sequence of cDNA encoding human insulin-like growth factor I precursor | Q34055481 | ||
Type II insulin-like growth factor receptor is present in rat serum | Q34360838 | ||
Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media | Q34521857 | ||
Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation | Q34568177 | ||
Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. | Q34578087 | ||
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. | Q34623199 | ||
Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor | Q34662007 | ||
Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor | Q35399674 | ||
The insulin-like growth factor II/mannose-6-phosphate receptor is present in fetal and maternal sheep serum | Q35445980 | ||
Organization of the human genes for insulin-like growth factors I and II. | Q36424456 | ||
Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous | Q36489597 | ||
Developmental pattern of a serum binding protein for multiplication stimulating activity in the rat | Q36983940 | ||
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia | Q37005523 | ||
Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier Protein | Q37038232 | ||
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay | Q37046720 | ||
Transferrin receptors in rat plasma | Q37484152 | ||
Binding proteins for the insulin-like growth factors: structure, regulation and function | Q38213635 | ||
Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations | Q38667678 | ||
ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY | Q40310947 | ||
Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein | Q40324347 | ||
The insulin-like growth factor I content in human milk increases between early and full lactation | Q68094588 | ||
Synthesis of placental protein 12 by human endometrium | Q68860949 | ||
The somatomedin-binding protein isolated from a human hepatoma cell line is identical to the human amniotic fluid somatomedin-binding protein | Q68933496 | ||
Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: evidence of immunological homology | Q68940631 | ||
Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid | Q68954920 | ||
Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells | Q68960481 | ||
Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies | Q68962393 | ||
Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial alpha 1- and alpha 2-globulins (alpha 1- and alpha 2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14) | Q68972514 | ||
Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from human cerebrospinal fluid | Q68974201 | ||
Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity | Q69002588 | ||
Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma | Q69002592 | ||
Binding proteins for insulin-like growth factors in adult rat serum. Comparison with other human and rat binding proteins | Q69004734 | ||
Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein | Q69024295 | ||
Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph | Q69036530 | ||
Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein | Q69042296 | ||
An insulin-like growth factor-binding protein in the baboon (Papio anubis) endometrium: synthesis, immunocytochemical localization, and hormonal regulation | Q69060875 | ||
Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I | Q69087278 | ||
Regulation of growth hormone-independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants | Q69087783 | ||
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue | Q69330348 | ||
Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth | Q69530637 | ||
Synthesis of placental protein 12 by decidua from early pregnancy | Q69571512 | ||
The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid | Q69586871 | ||
Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum | Q69620941 | ||
Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum | Q69636429 | ||
Regulation of plasma growth hormone-binding proteins in health and disease | Q69642220 | ||
Method for purification of an insulin-like growth factor-binding protein produced by human HEP G2 hepatoma cells | Q69809743 | ||
Alterations in the synthesis of a fibroblast surface associated 35 K protein modulates the binding of somatomedin-C/insulin-like growth factor I | Q69855141 | ||
Pregnancy proteins in seminal plasma, seminal vesicles, preovulatory follicular fluid, and ovary | Q69898806 | ||
Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins | Q70014596 | ||
Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man | Q70042655 | ||
Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture | Q70042658 | ||
Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action | Q70042936 | ||
Synthesis of placental protein 12 by human decidua | Q70059286 | ||
Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs | Q70060767 | ||
The insulin-like growth factor II/mannose-6-phosphate receptor is present in monkey serum | Q70060960 | ||
Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture | Q70078924 | ||
Rat hepatocyte insulin-like growth factor I and binding protein: effect of growth hormone in vitro and in vivo | Q70078928 | ||
Rat astroglial somatomedin/insulin-like growth factor binding proteins: characterization and evidence of biologic function | Q70215540 | ||
Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12 | Q70314889 | ||
Identification of human semen insulin-like growth factor-I/somatomedin-C immunoreactivity and binding protein | Q70366138 | ||
Comparison of three methods for investigating placental protein 12(PP12)-like immunoreactive substance from preovulatory follicular fluid and purified PP12 from human placenta | Q70642167 | ||
The somatomedin C binding protein: evidence for a heterologous subunit structure | Q71213709 | ||
[Isolation and characterization of a new placenta specific protein (PP12) (author's transl)] | Q71324488 | ||
Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum | Q72152941 | ||
Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid | Q72379032 | ||
Purification and characterization of multiplication-stimulating activity (MSA) carrier protein | Q72384676 | ||
Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture | Q72633834 | ||
Plasma Somatomedin-Binding Proteins in Hypopituitarism: Changes during Growth Hormone Therapy* | Q72636770 | ||
Somatomedin Peptide Distribution and Somatomedin-Binding Protein Content in Cord Plasma: Comparison to Normal and Hypopituitary Plasma* | Q72654475 | ||
Evidence for production by the liver of two IGF binding proteins with similar molecular weights but different affinities for IGF I and IGF II. Their relations with serum and cerebrospinal fluid IGF binding proteins | Q72670469 | ||
Synthesis and Secretion of Insulin-Like Growth Factor and Its Binding Protein by the Perfused Rat Liver: Dependence on Growth Hormone Status* | Q72701022 | ||
Affinity labeled somatomedin-C-binding proteins in rat sera | Q72727704 | ||
Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk | Q72733405 | ||
Preferential Measurement of Insulin-Like Growth Factor (IGF) I-Related Peptides in Serum with the Aid of IGF-Binding Proteins (IGF BPs) Produced by Rat Liver in Culture. Estimation of Serum IGF BP Levels* | Q72739287 | ||
Isolation of a Somatomedin-Binding Protein from Preterm Amniotic Fluid. Development of a Radioimmunoassay* | Q72745822 | ||
Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid | Q72747666 | ||
Non-suppressible insulin-like activity of human serum I. Physicochemical properties, extraction and partial purification | Q72909346 | ||
Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling | Q72919808 | ||
Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease | Q72955549 | ||
Comparison of [125I]Somatomedin A and [125I]Somatomedin C Radioreceptor Assays for Somatomedin Peptide Content in Whole and Acid-Chromatographed Plasma* | Q40469810 | ||
Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure | Q40927293 | ||
Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex | Q41253245 | ||
N-terminal amino acid sequence of human pregnancy-associated endometrial alpha 1-globulin, an endometrial insulin-like growth factor (IGF) binding protein--evidence for two small molecular weight IGF binding proteins | Q41253372 | ||
Further Characterization of Growth Hormone-Dependent Somatomedin-Binding Proteins in Rat Serum and Demonstration of Somatomedin-Binding Proteins Produced by Rat Liver Cells in Culture* | Q41620720 | ||
Different insulin-like growth factor binding species in human placenta and decidua | Q41956796 | ||
Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active | Q42074486 | ||
Purification of the serum acid-stable insulin-like growth factor binding protein from the pig (Sus scrofa). | Q42078690 | ||
Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. | Q42488878 | ||
Partial characterization of a somatomedin-like peptide from the medium of cultured rat Sertoli cells | Q42809719 | ||
Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells | Q43479530 | ||
Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. | Q43484195 | ||
Insulin-like growth factor (IGF-I) and its low molecular weight binding protein in human milk | Q43512257 | ||
Synthesis of multiplication-stimulating activity (rat insulin-like growth factor II) by rat embryo fibroblasts | Q43573922 | ||
The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding | Q43576453 | ||
Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. | Q43594130 | ||
Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma | Q43679769 | ||
The serum half-life of somatomedin activity: evidence for growth hormone dependence | Q43732698 | ||
Immunohistological localization of the human endometrial secretory protein pregnancy-associated endometrial alpha 1-globulin, an insulin-like growth factor-binding protein, during the menstrual cycle | Q44030513 | ||
Identification of insulin-like growth factor-binding protein-2 (IGF-BP-2) and a low molecular weight IGF-BP in human seminal plasma | Q44178453 | ||
Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors | Q44247696 | ||
Expression of the BRL-3A insulin-like growth factor binding protein (rBP-30) in the rat central nervous system | Q44268795 | ||
Ontogeny of serum insulin-like growth factor binding proteins in the rat. | Q44455038 | ||
The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells | Q44587214 | ||
Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo | Q44757115 | ||
A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. | Q44773209 | ||
Characterization of insulin-like growth factor binding proteins of cultured rat astroglial and neuronal cells | Q44792975 | ||
Specific binding of a somatomedin-like polypeptide in rat serum depends on growth hormone | Q44857464 | ||
Structural and immunohistochemical characterization of insulin-like growth factor I and II receptors in the murine central nervous system | Q44880375 | ||
Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties | Q44924361 | ||
Biosynthesis of the low molecular weight carrier protein for insulin-like growth factors in rat liver and fibroblasts | Q45050326 | ||
Primary structure of human insulin-like growth factor II. | Q45064062 | ||
Covalent cross-linking of insulin-like growth factor-1 to a specific inhibitor from human serum | Q45218264 | ||
Characterization of insulin-like growth factor-binding proteins in cultured rat pituitary cells. | Q45947885 | ||
Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells | Q46074971 | ||
The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. | Q46152496 | ||
Expression of two insulin-like growth factor-binding proteins in a human endometrial cancer cell line: structural, immunological, and genetic characterization | Q46307719 | ||
An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells | Q46361651 | ||
Characterization of insulin-like growth factor binding proteins from human breast cancer cells | Q46811297 | ||
Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines | Q46834265 | ||
A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA. | Q47172499 | ||
Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein | Q47174495 | ||
The ontogeny and regulation of a 31,000 molecular weight insulin-like growth factor-binding protein in fetal porcine plasma and sera | Q47181985 | ||
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein | Q47184585 | ||
Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. | Q48275415 | ||
Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant | Q48382286 | ||
Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. | Q48388321 | ||
The insulin-like growth factor-binding proteins of porcine serum: endocrine and nutritional regulation. | Q51620566 | ||
Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. | Q51623886 | ||
Regulation of the growth hormone-independent growth factor-binding protein in children. | Q51624187 | ||
Circulating insulin-like growth factor-binding proteins in fetal, neonatal and adult sheep. | Q52261243 | ||
A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts | Q54467718 | ||
Localization of insulin-like growth factor genes to human chromosomes 11 and 12 | Q59050810 | ||
Somatomedin: Proposed Designation for Sulphation Factor | Q59080510 | ||
Autocrine and paracrine growth regulation of human breast cancer | Q61625136 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | transport protein | Q2111029 |
P304 | page(s) | 99-159; discussion 159-63 | |
P577 | publication date | 1990-01-01 | |
P1433 | published in | Endocrine Reviews | Q3054007 |
P1476 | title | Insulinlike growth factor-binding proteins | |
Insulinlike Growth Factor-Binding Proteins | |||
P478 | volume | 46 |
Q28324041 | Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule |
Q27013698 | An ocular view of the IGF-IGFBP system |
Q47774249 | Collection of blood in heparinized tubes does not alter the molecular distribution or forms of IGFBP-3 and IGF. |
Q43870822 | Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH. |
Q54205557 | Differential removal of insulin-like growth factor binding proteins in rat serum by solvent extraction procedures. |
Q41955854 | Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function |
Q26766068 | Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma |
Q39649512 | Evaluation of IGF-I levels and serum protein profiles of diabetic cats and dogs |
Q38343400 | High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2 |
Q74631128 | IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man |
Q41693162 | IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth |
Q36707260 | Importance of receptor occupancy, concentration differences, and ligand exchange in the insulin-like growth factor I receptor system |
Q72096346 | Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure |
Q35586993 | Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer. |
Q28069262 | Is there a role for IGF-1 in the development of second primary cancers? |
Q71707226 | Nutritional insult and recovery in the neonatal rat cerebellum: insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) |
Q34167065 | Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia |
Q71688997 | Postsynthetic regulation of insulin-like growth factor-binding protein-3 by MCF-7 human breast cancer cells in culture |
Q33893929 | Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies |
Q48161013 | Proliferative growth of neonatal cerebellar cells in culture: regulation by male and by maternal serum in late gestation |
Q36234276 | Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. |
Q27006846 | Targeting the insulin-like growth factor pathway in hepatocellular carcinoma |
Q47873030 | The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children |
Q35343968 | The insulin-like growth factor family of ligands, receptors, and binding proteins |
Q41188349 | The regulation of L-proline transport by insulin-like growth factor-I in human osteoblast-like SaOS-2 cells |
Q35763492 | Thyroid hormones and growth hormone secretion |
Search more.